Valuation: Amoéba

Market Cap 50.29M 58.13M 46.96M 43.08M 81.03M 5.53B 82.31M 551M 216M 2.77B 218M 214M 9.17B P/E 2026 *
-9.73x
P/E 2027 * 73x
Enterprise Value 61.44M 71.03M 57.37M 52.63M 98.99M 6.76B 101M 673M 264M 3.39B 267M 261M 11.2B EV / Sales 2026 *
12x
EV / Sales 2027 * 4x
Free-Float
87.09%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 60 2023-12-13
Chief Tech/Sci/R&D Officer - 2018-08-31
Corporate Officer/Principal - 2022-02-28
Director TitleAgeSince
Director/Board Member 57 2024-04-30
Director/Board Member - 2014-05-31
Chairman 70 2023-12-13
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 58.13M
+0.49%-2.72%-14.78%-24.00% 3.28B
+1.19%+7.07%+10.05%-3.15% 2.21B
-1.27%+1.88%-21.30%-35.97% 1.81B
-1.47%-11.38%+14.83%-0.07% 1.67B
+0.04%-0.62%-23.85% - 1.5B
+0.48%-2.15%-15.22%-43.34% 1.41B
+0.22%-1.40%-27.80%+35.01% 1.34B
-0.67%-2.32%-6.18%-17.03% 1.32B
+3.84%+24.22%-27.93%+86.96% 1.17B
Average +0.28%+1.78%-12.47%-0.20% 1.75B
Weighted average by Cap. +0.26%+0.99%-11.16%-6.02%

Financials

2026 *2027 *
Net sales 5.1M 5.9M 4.76M 4.37M 8.22M 561M 8.35M 55.88M 21.93M 281M 22.14M 21.66M 930M 15.55M 17.98M 14.52M 13.32M 25.06M 1.71B 25.45M 170M 66.87M 858M 67.51M 66.03M 2.83B
Net income -5.2M -6.01M -4.86M -4.45M -8.38M -572M -8.51M -56.97M -22.36M -287M -22.57M -22.08M -948M 550K 636K 514K 471K 886K 60.51M 900K 6.03M 2.37M 30.33M 2.39M 2.34M 100M
Net Debt 11.15M 12.89M 10.41M 9.55M 17.97M 1.23B 18.25M 122M 47.95M 615M 48.41M 47.35M 2.03B 11.85M 13.7M 11.07M 10.15M 19.09M 1.3B 19.4M 130M 50.96M 653M 51.44M 50.32M 2.16B
Logo Amoéba
Amoéba is a greentech company whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. With know-how that is unique in the world and protected by numerous patents, Amoéba is currently the only company capable of exploiting the full potential of the Willaertia amoeba on an industrial scale and cultivating it in sufficient volumes to offer biological solutions that constitute a viable alternative to the chemical products widely used today. Amoéba is currently focusing on the global biocontrol market for plant protection and on the cosmetics market.
Employees
23
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.7300EUR
Average target price
1.400EUR
Spread / Average Target
+91.78%

Annual profits - Rate of surprise